GlassScriptPhysician profile
Christopher S Hogan
NPI 1932220233
$4,044.28
in general payments reported to CMS, 2019-2025
35 companies · $1,707 in 2025
The $1,707 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $58.20 · 2021: $324 · 2022: $647 · 2023: $626 · 2024: $329 · 2025: $1,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555 · Travel and Lodging: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.58 |
| Travel and Lodging | $1,108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,513.32 | 2024-2025 | Phasix Mesh |
| Tela Bio, INC. | $723.26 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Takeda Pharmaceuticals U.S.A., INC. | $274.82 | 2021-2025 | Gattex |
| Smith+Nephew, INC. | $200.63 | 2020-2023 | Oasis, Grafix Pl |
| Teleflex LLC | $167.58 | 2022-2023 | Quikclot |
| Genentech, INC. | $135.11 | 2019 | |
| Medtronic, INC. | $122.83 | 2021-2025 | Transorb |
| Intuitive Surgical, INC. | $115.87 | 2024 | |
| Ethicon US, LLC | $77.46 | 2020-2025 | N/A, Enseal, Harmonic |
| Acelrx Pharmaceuticals, INC. | $74.85 | 2019-2021 | |
| Acera Surgical, INC. | $64.32 | 2022-2025 | Restrata Wound Matrix |
| Hydrofera LLC | $59.77 | 2022-2024 | Hydrofera Blue |
| Endogastric Solutions, INC | $58.26 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $42.92 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $31.44 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $31.22 | 2019 | |
| Bsn Medical INC | $25.07 | 2025 | |
| Rti Surgical, INC | $24.37 | 2024 | |
| Molnlycke Health Care US, LLC | $24.13 | 2024 | Mepilex Border Post-Op Ag |
| Solventum Corporation | $23.57 | 2024 | Activ.A.C. |
| Innovation Technologies INC | $23.44 | 2025 | Irrisept |
| Aroa Biosurgery Incorporated | $23.00 | 2019 | |
| Trevena, INC. | $21.26 | 2022 | |
| Hologic Sales and Service, LLC | $19.35 | 2023 | Trident Specimen Radiography System, Localizer |
| Moximed, INC | $19.21 | 2025 | Misha Knee System, Small, Left |
| Csl Behring | $18.27 | 2019 | |
| Merit Medical Systems INC | $17.49 | 2024 | Savi Scout |
| Integra Lifesciences Corporation | $16.47 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Convatec INC. | $15.77 | 2019 | |
| Hollister Incorporated | $13.93 | 2025 | New Image |
| Boston Scientific Corporation | $13.90 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.31 | 2024 | Ribfix Blu Advantage |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2022 | |
| Prescient Surgical | $12.68 | 2019 | |
| Medline Industries LP | $12.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.